- Home
- YETI vs IDYA Comparison
YETI vs IDYA Comparison
Compare YETI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- IDYA
- Stock Information
- Founded
- YETI 2006
- IDYA 2015
- Country
- YETI United States
- IDYA United States
- Employees
- YETI N/A
- IDYA N/A
- Industry
- YETI Recreational Games/Products/Toys
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- YETI Consumer Discretionary
- IDYA Health Care
- Exchange
- YETI Nasdaq
- IDYA Nasdaq
- Market Cap
- YETI 2.7B
- IDYA 2.3B
- IPO Year
- YETI 2018
- IDYA 2019
- Fundamental
- Price
- YETI $35.53
- IDYA $32.84
- Analyst Decision
- YETI Buy
- IDYA Buy
- Analyst Count
- YETI 13
- IDYA 17
- Target Price
- YETI $38.83
- IDYA $48.20
- AVG Volume (30 Days)
- YETI 1.4M
- IDYA 1.3M
- Earning Date
- YETI 11-06-2025
- IDYA 11-04-2025
- Dividend Yield
- YETI N/A
- IDYA N/A
- EPS Growth
- YETI N/A
- IDYA N/A
- EPS
- YETI 2.10
- IDYA N/A
- Revenue
- YETI $1,822,000,000.00
- IDYA $7,000,000.00
- Revenue This Year
- YETI $3.23
- IDYA $90.17
- Revenue Next Year
- YETI $4.82
- IDYA $219.42
- P/E Ratio
- YETI $17.08
- IDYA N/A
- Revenue Growth
- YETI 3.63
- IDYA N/A
- 52 Week Low
- YETI $26.61
- IDYA $13.45
- 52 Week High
- YETI $45.25
- IDYA $33.64
- Technical
- Relative Strength Index (RSI)
- YETI 56.18
- IDYA 71.22
- Support Level
- YETI $35.34
- IDYA $28.17
- Resistance Level
- YETI $36.56
- IDYA $33.64
- Average True Range (ATR)
- YETI 1.08
- IDYA 1.62
- MACD
- YETI 0.27
- IDYA 0.44
- Stochastic Oscillator
- YETI 78.90
- IDYA 89.46
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.